BJC recorded revenues of $5.3 billion in 2018, up from $5 billion in 2017, according to audited financial documents. The increase was largely attributable to higher net patient service revenue, which climbed 11 percent year over year.
Despite the year-over-year revenue growth, BJC saw its operating income decrease in 2018 after factoring in expenses. The system’s expenses totaled $5.3 billion last year, up from $4.8 billion in 2017.
BJC’s operating income fell to $59.4 million in 2018, a 61 percent decrease from $154.3 million 2017.
After factoring in a significant decline in investment income, BJC ended 2018 with net income of $105.9 million, down from $431.3 million in the year prior.
More articles on healthcare finance:
New York hospital unable to collect $38M due to billing system problems
CMS terminates Missouri hospital’s Medicare contract
Investment losses hit Sutter Health’s bottom line
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
